Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From MGI PHARMA
More IVD Mergers: Agilent Buys Resolution, Hologic Acquires Diagenode
Hologic made its third big acquisition of 2021 and Agilent agreed to pay up to $695m for Resolution Bioscience to extend its precision oncology capabilities.
Eisai Joins PROTAC Club Through New Oncology Collab
Japanese firm joins increasing global interest in PROTAC approach to cancer as it links with UK university for drug discovery collaboration.
Eisai's New Venture Fund Looks To ‘Excavate’ Innovation
Japanese pharma firm’s new venture capital fund aims to support and gain access to external innovation both at home and in the US, while a new alliance with a Japanese tech services firm will pursue opportunities in digital health and dementia.
Sale of Invention May Block Its Patenting Even If Details Are Not Disclosed, Supreme Court Concludes
America Invents Act did not alter the meaning of "on sale," unanimous court finds, so a confidential sale can qualify as prior art.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.